Regis Healthcare (FRA:06K1) Marketable Securities: €0.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:06K1 Regis Healthcare Ltd FRA:06K1
56 GF Score
Price €3.70
GF Value €2.14
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Regis Healthcare Marketable Securities?

Regis Healthcare FRA:06K1 -2.12% 56 Marketable Securities is €0.0 Mil as of Dec. 2025. GuruFocus rates FRA:06K1 with a GF Score™ of 56/100 and a GF Value™ of €2.14 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Regis Healthcare's Marketable Securities for the quarter that ended in Dec. 2025 was €0.0 Mil.

Regis Healthcare  (FRA:06K1) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Regis Healthcare Marketable Securities Related Terms

Regis Healthcare Marketable Securities Historical Data

* Premium members only.

The historical data trend for Regis Healthcare's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regis Healthcare Marketable Securities Chart

Regis Healthcare Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Regis Healthcare Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:06K1
56GF Score
Regis Healthcare Ltd FRA:06K1
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Regis Healthcare Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €0.0 Mil mean?
Regis Healthcare (FRA:06K1) has a Marketable Securities of €0.0 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Regis Healthcare and its competitors.
Is Regis Healthcare's Marketable Securities too high?
Regis Healthcare's current Marketable Securities is €0.0 Mil. Overall, Regis Healthcare has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Regis Healthcare's Marketable Securities compare to HCA and THC?
Regis Healthcare's Marketable Securities of €0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Regis Healthcare and its competitors. Regis Healthcare's current Marketable Securities is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regis Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Regis Healthcare (FRA:06K1) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.14, compared to a current price of €3.70 — trading 72.9% above its estimated fair value. The current Marketable Securities is €0.0 Mil. Regis Healthcare's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Regis Healthcare (FRA:06K1), the current Marketable Securities is €0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Regis Healthcare (FRA:06K1) Overvalued in 2026?

Based on GuruFocus' analysis, Regis Healthcare stock appears to be overvalued. The current stock price of €3.70 is trading 72.9% above its estimated GF Value™ of €2.14. GuruFocus considers Regis Healthcare to be Significantly Overvalued.

Key valuation signals for FRA:06K1:

  • Marketable Securities: €0.0 Mil
  • GF Value™: €2.14 vs. price of €3.70 (72.9% above fair value)
  • GF Score™: 56/100 with 4 warning signs

No single metric tells the full story. See the FRA:06K1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Regis Healthcare Business Description

Other Exchanges REG:Australia
Address 293 Camberwell Road, Level 2, Camberwell, Melbourne, VIC, AUS, 3124
Regis Healthcare is an Australian residential aged care operator providing accommodation and care for individuals who require high levels of support due to health or mobility issues. Residents are typically over 85 years old and are typified by dementia, palliative care, incontinence, and falls risk. Regis also operates smaller retirement village and home care businesses.
56GF Score

Get the complete analysis for FRA:06K1

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.70
Price
€2.14
GF Value